Sequencing Studies Offer Insight into Impact of Clonal Evolution on Cancer Treatment and Diagnosis | GenomeWeb

By Monica Heger

Cancer has long been known to be a heterogeneous disease, but the extent to which the genomes of cancer cells within a single tumor vary and evolve is just now beginning to be resolved by next-generation sequencing with important implications for therapeutics and diagnosis.

Clonal evolution is "important to cancer biology and important to our understanding of the way we treat cancer," Sam Aparicio of the University of British Columbia and BC Cancer Agency told Clinical Sequencing News.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.